Kappa deleting element as an alternative molecular target for minimal residual disease assessment by real-time quantitative PCR in patients with multiple myeloma
- 18 July 2012
- journal article
- research article
- Published by Wiley in European Journal of Haematology
- Vol. 89 (4) , 328-335
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1Blood, 2011
- Depth of response assessed by quantitative ASO‐PCR predicts the outcome after stem cell transplantation in multiple myelomaEuropean Journal of Haematology, 2010
- Major Tumor Shrinking and Persistent Molecular Remissions After Consolidation With Bortezomib, Thalidomide, and Dexamethasone in Patients With Autografted MyelomaJournal of Clinical Oncology, 2010
- New drugs in multiple myeloma: mechanisms of action and phase I/II clinical findingsThe Lancet Oncology, 2008
- Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantationBlood, 2008
- Evaluation of minimal residual disease in multiple myeloma patients by fluorescent‐polymerase chain reaction: the prognostic impact of achieving molecular responseBritish Journal of Haematology, 2008
- Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical StudyJournal of Clinical Oncology, 2007
- High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMABlood, 2005
- High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple MyelomaNew England Journal of Medicine, 2003
- Flow cytometric disease monitoring in multiple myeloma: the relationship between normal and neoplastic plasma cells predicts outcome after transplantationBlood, 2002